Natera legal chief exercises options, sells 8,398 shares

Natera, Inc. executive Daniel Rabinowitz, the Secretary and Chief Legal Officer, exercised options to acquire 5,598 shares of common stock at an exercise price of $19.68 per share.

Rhea-AI Filing Summary

Natera, Inc. executive Daniel Rabinowitz, the Secretary and Chief Legal Officer, exercised options to acquire 5,598 shares of common stock at an exercise price of $19.68 per share. These options were fully exercisable.

On the same date, he sold a total of 8,398 shares of Natera common stock in open-market transactions at weighted-average prices disclosed between $193.27 and $198.32 per share, pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2025. After these transactions, he continued to hold 233,285 shares of Natera common stock directly.

Insider Trade Summary 10b5-1

Exercise and sale activity reported; no spread calculated

Exercise and Sale 7 txns

Insider RABINOWITZ DANIEL

Role SEC. AND CHIEF LEGAL OFFICER

Sold 8,398 shs ($1.65M)

Approx. gross sale proceeds $1.65M

Approx. exercise cost $110K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	5,598	$0.00	$0.00
Exercise	Common Stock	5,598	$19.68	$110K
Sale	Common Stock	400	$193.7279	$77K
Sale	Common Stock	2,900	$194.7698	$565K
Sale	Common Stock	1,600	$195.7954	$313K
Sale	Common Stock	1,500	$196.9374	$295K
Sale	Common Stock	1,998	$198.0448	$396K

Holdings After Transaction: Stock Option (Right to Buy) — 0 contracts (Direct); Common Stock — 233,285 shares (Direct)

Footnotes (7)

1. F1. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025.
2. F2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.27 to $194.02 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. F3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.27 to $195.25 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4. F4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $195.32 to $196.26 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
5. F5. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $196.42 to $197.38 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
6. F6. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $197.45 to $198.32 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
7. F7. The option shares are fully exercisable.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Natera (NTRA) executive Daniel Rabinowitz report in this Form 4?

Daniel Rabinowitz reported exercising stock options and selling Natera common shares. He exercised 5,598 options at $19.68 per share and sold 8,398 shares in multiple open-market trades, while continuing to hold 233,285 Natera shares directly afterward.

How many Natera (NTRA) shares did Daniel Rabinowitz sell and at what prices?

He sold 8,398 Natera common shares in several open-market transactions. The weighted-average prices were based on trades within ranges from $193.27 up to $198.32 per share, with detailed price breakdowns available upon written request from the holder.

What stock options did Daniel Rabinowitz exercise in Natera (NTRA)?

He exercised options covering 5,598 shares of Natera common stock. The options had an exercise price of $19.68 per share and were fully exercisable at the time, converting the derivative position into directly held common shares before subsequent sales.

Were Daniel Rabinowitz’s Natera (NTRA) share sales under a Rule 10b5-1 plan?

Yes. The Form 4 states the share sales were effected under a Rule 10b5-1 trading plan. That plan was adopted on December 5, 2025, indicating the transactions were pre-arranged rather than newly timed decisions based on recent market developments.

How many Natera (NTRA) shares does Daniel Rabinowitz hold after these transactions?

Following the option exercise and subsequent sales, Daniel Rabinowitz directly holds 233,285 shares of Natera common stock. This post-transaction number reflects his remaining direct ownership reported in the filing after all trades on March 6, 2026 were completed.

What is the overall share impact of Daniel Rabinowitz’s Natera (NTRA) transactions?

He exercised 5,598 options to acquire Natera shares and sold 8,398 shares, resulting in a net reduction of 8,398 shares in his directly held position. Despite this, he still directly owns 233,285 Natera common shares as reported after the transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/10/2026 - 09:05 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

RABINOWITZ DANIEL

(Last) (First) (Middle)

C/O NATERA, INC.

13011 MCCALLEN PASS BUILDING A SUITE 100

(Street)

AUSTIN TX 78753

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Natera, Inc. [ NTRA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SEC. AND CHIEF LEGAL OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
03/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/06/2026		M		5,598	A	$19.68	241,683	D
Common Stock	03/06/2026		S		400(1)	D	$193.7279(2)	241,283	D
Common Stock	03/06/2026		S		2,900(1)	D	$194.7698(3)	238,383	D
Common Stock	03/06/2026		S		1,600(1)	D	$195.7954(4)	236,783	D
Common Stock	03/06/2026		S		1,500(1)	D	$196.9374(5)	235,283	D
Common Stock	03/06/2026		S		1,998(1)	D	$198.0448(6)	233,285	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$19.68	03/06/2026		M			5,598	(7)	03/21/2029	Common Stock	5,598	$0	0	D

Explanation of Responses:

1. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025.

2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.27 to $194.02 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.27 to $195.25 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $195.32 to $196.26 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

5. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $196.42 to $197.38 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

6. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $197.45 to $198.32 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

7. The option shares are fully exercisable.

	/s/ Tami Chen, Attorney-in-Fact	03/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.